AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30956% above fair value
$55.39+1.28 (+2.37%)
Close on Nov 20, 2026Market cap $2.82BP/E 263.8Yield –
AtriCure free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
AtriCure's free cash flow for the twelve months ending Jun 30, 2026 was $53.11M, up 110.0% year over year. For fiscal 2025 it was $48.28M, up 6381.1% from the year before. The highest annual figure on record is $48.28M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.28M | +6381.1% |
| FY2024 | Dec 31, 2024 | $745.00K | – |
| FY2023 | Dec 31, 2023 | -$7.51M | – |
| FY2022 | Dec 31, 2022 | -$39.02M | – |
| FY2021 | Dec 31, 2021 | -$23.53M | – |
| FY2020 | Dec 31, 2020 | -$25.13M | – |
| FY2019 | Dec 31, 2019 | -$27.99M | – |
| FY2018 | Dec 31, 2018 | -$10.38M | – |
| FY2017 | Dec 31, 2017 | -$15.33M | – |
| FY2016 | Dec 31, 2016 | -$22.81M | – |
| FY2015 | Dec 31, 2015 | -$21.29M | – |
| FY2014 | Dec 31, 2014 | -$27.11M | – |
| FY2013 | Dec 31, 2013 | -$8.09M | – |
| FY2012 | Dec 31, 2012 | -$4.92M | – |
| FY2011 | Dec 31, 2011 | -$3.51M | – |
| FY2010 | Dec 31, 2010 | -$1.85M | – |
| FY2009 | Dec 31, 2009 | -$940.51K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.43M | -2.8% |
| Q1 FY2026 | Mar 31, 2026 | -$7.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $18.43M | +486.2% |
| Q3 FY2025 | Sep 30, 2025 | $24.11M | +47.1% |
| Q2 FY2025 | Jun 30, 2025 | $18.96M | +279.4% |
| Q1 FY2025 | Mar 31, 2025 | -$13.21M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.14M | +152.7% |
| Q3 FY2024 | Sep 30, 2024 | $16.40M | – |
| Q2 FY2024 | Jun 30, 2024 | $5.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.79M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.11M | – |
| Q2 FY2023 | Jun 30, 2023 | -$69.00K | -253.3% |
| Q1 FY2023 | Mar 31, 2023 | -$6.58M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.13M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.93M | – |
| Q2 FY2022 | Jun 30, 2022 | $45.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.01M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.41M | -183.0% |
| Q3 FY2021 | Sep 30, 2021 | -$1.74M | -168.1% |
| Q2 FY2021 | Jun 30, 2021 | -$8.75M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.64M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.90M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.66M | -1367.3% |
| Q1 FY2020 | Mar 31, 2020 | -$17.92M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.89M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.96M | -267.5% |
| Q2 FY2019 | Jun 30, 2019 | $999.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$15.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$98.00K | -135.1% |
| Q3 FY2018 | Sep 30, 2018 | $3.56M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.32M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.52M | – |
| Q4 FY2017 | Dec 31, 2017 | $279.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.52M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.82M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.27M | – |
| Q4 FY2016 | Dec 31, 2016 | -$829.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$685.00K | – |
See a number that looks wrong?